Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies

Elife. 2022 Mar 23:11:e73006. doi: 10.7554/eLife.73006.

Abstract

PML nuclear bodies (PML-NBs) are dynamic interchromosomal macromolecular complexes implicated in epigenetic regulation as well as antiviral defense. During herpesvirus infection, PML-NBs induce epigenetic silencing of viral genomes, however, this defense is antagonized by viral regulatory proteins such as IE1 of human cytomegalovirus (HCMV). Here, we show that PML-NBs undergo a drastic rearrangement into highly enlarged PML cages upon infection with IE1-deficient HCMV. Importantly, our results demonstrate that dual signaling by interferon and DNA damage response is required to elicit giant PML-NBs. DNA labeling revealed that invading HCMV genomes are entrapped inside PML-NBs and remain stably associated with PML cages in a transcriptionally repressed state. Intriguingly, by correlative light and transmission electron microscopy (EM), we observed that PML cages also entrap newly assembled viral capsids demonstrating a second defense layer in cells with incomplete first-line response. Further characterization by 3D EM showed that hundreds of viral capsids are tightly packed into several layers of fibrous PML. Overall, our data indicate that giant PML-NBs arise via combined interferon and DNA damage signaling which triggers entrapment of both nucleic acids and proteinaceous components. This represents a multilayered defense strategy to act in a cytoprotective manner and to combat viral infections.

Keywords: PML protein; cytomegalovirus; herpesvirus; infectious disease; intrinsic immunity; microbiology; nuclear bodies; viruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents
  • DNA Damage
  • Epigenesis, Genetic
  • Humans
  • Interferons* / metabolism
  • Nuclear Bodies
  • Nuclear Proteins* / metabolism
  • Promyelocytic Leukemia Protein / genetics
  • Transcription Factors / metabolism

Substances

  • Antiviral Agents
  • Nuclear Proteins
  • Promyelocytic Leukemia Protein
  • Transcription Factors
  • Interferons

Grants and funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.